When will Original GENENTECH reps come to reality ???

Quote

Anonymous

Guest
Since Roche bought Genentech we have had nothing but worthless, lazy, overpaid dead beats rolled in from original Genentech sale forces and others. I hate working with them and wonder when this will be addressed.
 
























Anonymous said:
We will be gone if we dont have a product. Just as Oncology, Opth, Rheum, etc will be gone if they dont have a product to sell. We have some blockbuster potential products in the pipeline, so long term PC is here to stay.
Click to expand...

Right, long term PC is here to stay(after the PC sales force is all fired in March and genentech hires another PC sales force 2 or 3 years down the road)
 






Anonymous said:
Right, long term PC is here to stay(after the PC sales force is all fired in March and genentech hires another PC sales force 2 or 3 years down the road)
Click to expand...

THe point being that the company is not anti PC! They are anti carrying a sales force when there is nothing to sell. If Avastin went away, they would fire all of the avastin reps, etc. There is a chance that there will be a ramp up dalcetrapib relatively soon, but if not the rest of PC is likely to be terminated. Again, not because they are inferior, not because they are not liked. They are viewed as very capable and among the most skilled and battle tested reps in the company:

- They can sell more than one product at time
- They have thrive in highly competitive environments
- They have the proven ability to learn new therapeutic areas, and execute quickly (see Xolair, and many other specialty products in the last few years.)
- They are as well educated as any other force in the company
- They deliver lunches as good as their "biotech colleagues"
- They give the "10 second" sales pitch as good as anyone
 












Anonymous said:
THe point being that the company is not anti PC! They are anti carrying a sales force when there is nothing to sell. If Avastin went away, they would fire all of the avastin reps, etc. There is a chance that there will be a ramp up dalcetrapib relatively soon, but if not the rest of PC is likely to be terminated. Again, not because they are inferior, not because they are not liked. They are viewed as very capable and among the most skilled and battle tested reps in the company:

- They can sell more than one product at time
- They have thrive in highly competitive environments
- They have the proven ability to learn new therapeutic areas, and execute quickly (see Xolair, and many other specialty products in the last few years.)
- They are as well educated as any other force in the company
- They deliver lunches as good as their "biotech colleagues"
- They give the "10 second" sales pitch as good as anyone
Click to expand...

thanks nancy
 












Anonymous said:
THe point being that the company is not anti PC! They are anti carrying a sales force when there is nothing to sell. If Avastin went away, they would fire all of the avastin reps, etc. There is a chance that there will be a ramp up dalcetrapib relatively soon, but if not the rest of PC is likely to be terminated. Again, not because they are inferior, not because they are not liked. They are viewed as very capable and among the most skilled and battle tested reps in the company:

- They can sell more than one product at time
- They have thrive in highly competitive environments
- They have the proven ability to learn new therapeutic areas, and execute quickly (see Xolair, and many other specialty products in the last few years.)
- They are as well educated as any other force in the company
- They deliver lunches as good as their "biotech colleagues"
- They give the "10 second" sales pitch as good as anyone
Click to expand...

Hey pass that joint this way.
 






Anonymous said:
hahaha....Genentech is totally anti PC Lassie!
Click to expand...

Sorry, ROCHE is pro Money. MOST of the big drugs in the pipeline are primary care drugs. Dalcetripib for example. Of course, if you can have drugs that meet niche needs that is great, however that is a reflection on the drug not the rep. Remember, a rep is a rep. The ONLY difference between a primary care rep, and others is the product that they are trained to sell, nothing else. Primary care reps have trained to sell Lytics, they have sold Xolair, they have sold Nutropin.
 






Anonymous said:
Sorry, ROCHE is pro Money. MOST of the big drugs in the pipeline are primary care drugs. Dalcetripib for example. Of course, if you can have drugs that meet niche needs that is great, however that is a reflection on the drug not the rep. Remember, a rep is a rep. The ONLY difference between a primary care rep, and others is the product that they are trained to sell, nothing else. Primary care reps have trained to sell Lytics, they have sold Xolair, they have sold Nutropin.
Click to expand...

If only that were true, we might have some hope.
 


















Anonymous said:
Remember, a rep is a rep. The ONLY difference between a primary care rep, and others is the product that they are trained to sell, nothing else.
Click to expand...

The Actemra team has proved that is not true.
When you don't value people for their unique skills- assume the lowest level for everyone- you will get the lowest performance.
There IS a difference between "Biotech" and Pharma. That is the difference between worrying about call averages & activity vs. being considered a benefit to the office. To servicing your accounts and working for patients vs. "hitting your metrics".
There is a big difference in the type of reps out there... and by thinking there isn't, you are dismissive and naive.
 






Anonymous said:
Since Roche bought Genentech we have had nothing but worthless, lazy, overpaid dead beats rolled in from original Genentech sale forces and others. I hate working with them and wonder when this will be addressed.
Click to expand...


Actually, you don't work with them. They're all sitting back overlooking their vinyards or cruising on their yachts. Get a clue.
 






Anonymous said:
The Actemra team has proved that is not true.
When you don't value people for their unique skills- assume the lowest level for everyone- you will get the lowest performance.
There IS a difference between "Biotech" and Pharma. That is the difference between worrying about call averages & activity vs. being considered a benefit to the office. To servicing your accounts and working for patients vs. "hitting your metrics".
There is a big difference in the type of reps out there... and by thinking there isn't, you are dismissive and naive.
Click to expand...



you are correct......... that aunt jemiema woman with acterma doesn't have a clue. and the packie who hired her for his own job security better start looking for a new job........
 


















Top Bottom
Back
Quote